Modulating Fingolimod (FTY720) Anti-SARS-CoV-2 Activity Using a PLGA-Based Drug Delivery System
- 22 June 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (7) , 3371-3383
Abstract
COVID-19 has resulted in more than 490 million people being infected worldwide, with over 6 million deaths by April 05th, 2022. Even though the development of safe vaccine options is an important step to reduce viral transmission and disease progression, COVID-19 cases will continue to occur, and for those cases, efficient treatment remains to be developed. Here, a drug repurposing strategy using nanotechnology is explored to develop a therapy for COVID-19 treatment. Nanoparticles (NPs) based on PLGA for fingolimod (FTY720) encapsulation show a size of ∼150 nm and high drug entrapment (∼90%). The NP (NP@FTY720) can control FTY720 release in a pH-dependent manner. Cytotoxicity assays using different cell lines show that NP@FTY720 displays less toxicity than the free drug. Flow cytometry and confocal microscopy reveal that NPs are actively internalized mostly through caveolin-mediated endocytosis and macropinocytosis pathways and co-localized with lysosomes. Finally, NP@FTY720 not only exhibits anti-SARS-CoV-2 activity at non-cytotoxic concentrations, but its biological potential for viral infection inhibition is nearly 70 times higher than that of free drug treatment. Based on these findings, the combination of drug repurposing and nanotechnology as NP@FTY720 is presented for the first time and represents a promising frontline in the fight against COVID-19.Keywords
Funding Information
- Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo (2015/26722-8, 2018/08820-0, 2019/25645-0, 2020/12277-0)
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (88887.506832/2020-00)
This publication has 68 references indexed in Scilit:
- Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound LibrarySLAS Discovery, 2022
- Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cellsJournal of Pharmacy and Pharmacology, 2014
- Fingolimod (FTY720): First approved oral therapy for multiple sclerosisJournal of Pharmacology and Pharmacotherapeutics, 2011
- High‐Resolution 3D Quantitative Analysis of Caveolar Ultrastructure and Caveola–Cytoskeleton InteractionsTraffic, 2008
- Pathways of clathrin-independent endocytosisNature Reviews Molecular Cell Biology, 2007
- On the use of the Weibull function for the discernment of drug release mechanismsInternational Journal of Pharmaceutics, 2006
- Regulated portals of entry into the cellNature, 2003
- Mechanisms of Potassium Chloride Release from Compressed, Hydrophilic, Polymeric Matrices: Effect of Entrapped AirJournal of Pharmaceutical Sciences, 1983
- Mechanisms of solute release from porous hydrophilic polymersInternational Journal of Pharmaceutics, 1983
- Letters to the Editor: Linearization of dissolution rate curves by the Weibull distributionJournal of Pharmacy and Pharmacology, 1972